Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.

Eva Waite, Eric E Schadt, Robert J Desnick, Judy H Cho, Pamela Sklar, Kurt Hirschhorn, Erwin P Bottinger, Inga Peter, Jean-Sébastien Hulot, Andrew Kasarskis, Lisa Edelmann, Jonathan L Halperin, Joel Dudley, George A Diaz, Stuart A Scott, Aida Vega, Eimear E Kenny, Hetanshi Naik, Paola Nicoletti, Rong Chen, Xiang Zhou, Tom Kaszemacher, Richard Wallsten, Stephen B Ellis, Erick R Scott, Yao Yang, Mariana R Botton, Aniwaa Owusu Obeng

Journal: Pharmacogenomics 2018;18(15):1381-1386

PMID: 28982267

Free Full Text on PubMed Central View on PubMed

Abstract

For almost 50 years, the Icahn School of Medicine at Mount Sinai has continually invested in genetics and genomics, facilitating a healthy ecosystem that provides widespread support for the ongoing programs in translational pharmacogenomics. These programs can be broadly cataloged into discovery, education, clinical implementation and testing, which are collaboratively accomplished by multiple departments, institutes, laboratories, companies and colleagues. Focus areas have included drug response association studies and allele discovery, multiethnic pharmacogenomics, personalized genotyping and survey-based education programs, pre-emptive clinical testing implementation and novel assay development. This overview summarizes the current state of translational pharmacogenomics at Mount Sinai, including a future outlook on the forthcoming expansions in overall support, research and clinical programs, genomic technology infrastructure and the participating faculty.

Address: Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY 10029, USA.; Sema4, a Mount Sinai venture, Stamford, CT 06902, USA.; The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, NY 10029, USA.; Department of Pharmacy, the Mount Sinai Medical Center, NY 10029, USA.; Icahn Institute for Genomics & Multiscale Biology, Icahn School of Medicine at Mount Sinai, NY 10029, USA.; Mount Sinai Faculty Practice Associates Primary Care Program, Icahn School of Medicine at Mount Sinai, NY 10029, USA.; Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, NY 10029, USA.; The Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, NY 10029, USA.; Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, NY 10029, USA.; Sorbonne Universités, UPMC Univ Paris 06, Faculty of Medicine, UMRS_1166 ICAN, Institute of Cardiometabolism & Nutrition, AP-HP, Pitié-Salpêtrière Hospital, Institute of Cardiology, Paris, France.; Berlin Institute of Health, Berlin, Germany.; Department of Psychiatry & Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, NY 10029, USA.; Department of Medicine, Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, NY 10029 USA.

DOI: 10.2217/pgs-2017-0137

Link outs

Free resources

Full Text Sources:

Other Literature Sources:

https://scite.ai/reports/28982267

Subscription / membership required

Full Text Sources:

https://www.tandfonline.com/doi/10.2217/pgs-2017-0...

MeSH Terms: Alleles, Genome, Genomics, Humans, Pharmacogenetics, Precision Medicine, Schools, Medical, Translational Research, Biomedical